TrialMedical oncology (Northwood, London, England)2011

Phase I/II randomised study of a novel erythropoiesis-stimulating agent (AMG 114) for the treatment of anaemia with concomitant chemotherapy in patients with non-myeloid malignancies.

Richard de Boer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.